Literature DB >> 16467880

Phosphorylated KDR can be located in the nucleus of neoplastic cells.

Cristina Blazquez1, Nathan Cook, Kingsley Micklem, Adrian L Harris, Kevin C Gatter, Francesco Pezzella.   

Abstract

KDR (kinase insert domain receptor) phosphorylation induces several effects which lead eventually to cell proliferation and survival. The precise mechanisms by which KDR, once it is activated, communicates with the nucleus are starting to be understood but have not yet been completely unravelled. Two in vitro studies on animal cell lines reported in the literature have demonstrated that, following stimulation with VEGF, KDR is actually translocated within the nucleus. Our aim was to investigate whether this translocation occurs in human cells both in vitro and in vivo. Using laser scanning confocal microscopy, a variable nuclear localization of phosphorylated and total KDR in cell lines and tumour samples was found. In human neoplastic cell lines, hypoxic stimulation greatly increased the nuclear amount of total KDR but less so that of the phosphorylated form. Only after hypoxia and VEGF stimulation there was a comparably increased expression of phosphorylated and total KDR observed in the nuclei of these cells. We conclude that neoplastic cells show a variable expression of total and phosphorylated KDR in the nucleus. The precise functional meaning of nuclear location remains to be established.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16467880     DOI: 10.1038/sj.cr.7310012

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  14 in total

1.  Effect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivo.

Authors:  Monika Edelbauer; Dipak Datta; Ingrid H C Vos; Aninda Basu; Maria P Stack; Marlies E J Reinders; Masayuki Sho; Katiana Calzadilla; Peter Ganz; David M Briscoe
Journal:  Blood       Date:  2010-06-10       Impact factor: 22.113

2.  VEGFR2 translocates to the nucleus to regulate its own transcription.

Authors:  Inês Domingues; José Rino; Jeroen A A Demmers; Primal de Lanerolle; Susana Constantino Rosa Santos
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

3.  Cutting edge: Vascular endothelial growth factor-mediated signaling in human CD45RO+ CD4+ T cells promotes Akt and ERK activation and costimulates IFN-gamma production.

Authors:  Aninda Basu; Andre Hoerning; Dipak Datta; Monika Edelbauer; Maria P Stack; Katiana Calzadilla; Soumitro Pal; David M Briscoe
Journal:  J Immunol       Date:  2009-12-11       Impact factor: 5.422

4.  Embryoid body formation of human amniotic fluid stem cells depends on mTOR.

Authors:  A Valli; M Rosner; C Fuchs; N Siegel; C E Bishop; H Dolznig; U Mädel; W Feichtinger; A Atala; M Hengstschläger
Journal:  Oncogene       Date:  2009-11-23       Impact factor: 9.867

Review 5.  Vascular endothelial growth factor signaling in acute myeloid leukemia.

Authors:  Kim R Kampen; Arja Ter Elst; Eveline S J M de Bont
Journal:  Cell Mol Life Sci       Date:  2012-07-26       Impact factor: 9.261

Review 6.  Systems biology of vascular endothelial growth factors.

Authors:  Feilim Mac Gabhann; Aleksander S Popel
Journal:  Microcirculation       Date:  2008-11       Impact factor: 2.628

7.  Nuclear VEGFR-2 Expression of Hepatocytes Is Involved in Hepatocyte Proliferation and Liver Regeneration During Chronic Liver Injury.

Authors:  A-Rang Lee; Su-Min Baek; Seoung-Woo Lee; Tae-Un Kim; Jee Eun Han; Seulgi Bae; Sang-Joon Park; Tae-Hwan Kim; Kyu-Shik Jeong; Seong-Kyoon Choi; Jin-Kyu Park
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

8.  Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells.

Authors:  S Lamorte; S Ferrero; S Aschero; L Monitillo; B Bussolati; P Omedè; M Ladetto; G Camussi
Journal:  Leukemia       Date:  2011-10-25       Impact factor: 11.528

9.  The -271 G>A polymorphism of kinase insert domain-containing receptor gene regulates its transcription level in patients with non-small cell lung cancer.

Authors:  She-Juan An; Zhi-Hong Chen; Qiu-Xiong Lin; Jian Su; Hua-Jun Chen; Jia-Ying Lin; Yi-Long Wu
Journal:  BMC Cancer       Date:  2009-05-12       Impact factor: 4.430

Review 10.  gamma-Secretase: a multifaceted regulator of angiogenesis.

Authors:  Michael E Boulton; Jun Cai; Maria B Grant
Journal:  J Cell Mol Med       Date:  2008-02-08       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.